Effectiveness of influenza vaccine in aging and older adults: Comprehensive analysis of the evidence

Clinical Interventions in Aging

Volumn 7, Issue , 2012, Pages 55-64

  Lang, Pierre Olivier ^a,b   Mendes, Aline ^a   Socquet, Jennifer ^a   Assir, Noémie ^a   Govind, Sheila ^b   Aspinall, Richard ^b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b CRANFIELD UNIVERSITY   (United Kingdom)

Author keywords

Hemagglutinin activity inhibition; Hemagglutinin inhibition; Immunosenescence; Influenza vaccine effectiveness; Influenza virus infection; Innate immunity; Older adults

Indexed keywords

INFLUENZA VACCINE; PLACEBO;

AGING; ANTIBODY RESPONSE; CAUSE OF DEATH; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG INFORMATION; ELDERLY CARE; EVIDENCE BASED MEDICINE; HERD IMMUNITY; HIGH RISK POPULATION; HUMAN; IMMUNOSTIMULATION; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; INFLUENZA; INFLUENZA VACCINATION; OUTCOME ASSESSMENT; PNEUMONIA; REVIEW; RISK ASSESSMENT; TREATMENT RESPONSE; AGED; ATTITUDE TO HEALTH; EPIDEMIC; HEALTH STATUS; RESPIRATORY TRACT DISEASE; SEASON;

AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; DISEASE OUTBREAKS; EVIDENCE-BASED MEDICINE; HEALTH SERVICES FOR THE AGED; HEALTH STATUS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; RESPIRATORY TRACT DISEASES; SEASONS;

EID: 84861957178     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S25215     Document Type: Review

References (83)

1. World Health Organization (WHO). Influenza (Seasonal). Fact sheet NN211. April 2009. [updated 2011]. Available from: http://www.who. int/mediacentre/factsheets/fs211/en/. Accessed November 30, 2011.
2. Centers for Disease Control and Prevention (CDC). Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2011;60(33):1128-1132.
3. National Advisory Committee on Immunization. Statement on seasonal influenza vaccine for 2011-2012. Canada Communicable Disease Report (CCDR). 2011;37(ACS5):1-55 [updated 2011]. Available from: http:// www.phac-aspc.gc.ca/publicat/ccdr-rmtc/11vol37/acs-dcc-5/assets/pdf/ acs-dcc-5-eng.pdf. Accessed October 30, 2011.
4. Michiels B, Govearts F, Remmen R, Vermeire E, Coenen S. A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups. Vaccine. 2011;29(49): 9159-9170.
5. European Centre for Disease Prevention Control. Seasonal human influenza and vaccination. [updated 2011]. Available from: http://www. ecdc.europa.eu/en/press/Press%20Releases/071012_P R_SI_Prof_Fact_ Sheet.pdf. Accessed October 30, 2011.
6. Monto AS. Seasonal influenza and vaccination coverage. Vaccine. 2010; 28 (Suppl 4):D33-D44.
7. Michel JP, Lang PO, Baeyens JP. Flu vaccination policy in old adults: need for harmonization of national public health recommendations throughout Europe. Vaccine. 2009;27(2):182-183.
8. Parodi V, de Florentiis D, Martini M, Ansaldi F. Inactivated influenza vaccines: recent progress and implication for the elderly. Drugs Aging. 2011;28(2):93-106.
9. Monto AS, Ansaldi F, Aspinall R, et al. Influenza control in the 21st century: optimizing protection for older adults. Vaccine. 2009;27(37): 5043-5053.
10. Lang PO, Govind S, Mitchell WA, Siegrist CA, Aspinall R. Vaccine effectiveness in older individuals: What has been learned from influenza-vaccine experience. Ageing Res Rev. 2011;10(3):389-395.
11. Lang PO, Govind S, Mitchell WA, et al. Influenza vaccine effectiveness in aged individuals: the role played by cell-mediated immunity. Eur Geriatr Med. 2010;1(2):233-238.
12. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis. 2007;7(10):658-666.
13. Beigel JH. Influenza. Crit Care Med. 2008;36(9):2660-2666.
14. World Health Organization. Influenza vaccines. Wkly Epidemiol Rec. 2005;80(33):279-287.
15. McElhaney JE. The unmet need in the elderly: designing new influenza vaccines for older adults. Vaccine. 2005;23 (Suppl 1):S10-S25.
16. Greenberg HB, Piedra PA. Immunization against viral respiratory disease: a review. Pediatr Infect Dis J. 2004;23 (Suppl 11):S254-S261.
17. Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis. 2002; 2(11):659-666.
18. Barker WH, Borisute H, Cox C. A study of the impact of influenza on the functional status of frail older people. Arch Intern Med. 1998;158(6): 645-650.
19. Molinari NA, Ortega-Sanchez IR, Messonier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25(27):5086-5096.
20. Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med. 2007;357(14):1373-1381.
21. Deans GD, Stiver HG, McElhaney JE. Influenza vaccines provide diminished protection but are cost-saving in older adults. J Intern Med. 2010;267(2):220-227.
22. Maciosek MV, Solberg LI, Coffield AB, Edwards NM, Goodman MJ. Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older. Am J Prev Med. 2006;31(1): 72-79.
23. Centers for Disease Control and Prevention. Recommendation of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2004;53(RR-06):1-40.
24. Jefferson T, Di Pietrantonj C, Rivetti A, Bawazeer GA, Al Ansary, Ferroni E. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2007:CD001269.
25. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994;272(21):1661-1665.
26. Nelson JC, Jackson ML, Weiss NS, Jackson LA. New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among senior. J Clin Epidemiol. 2009;62(7):687-694.
27. Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet. 2005;366(9492):1165-1174.
28. Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2010:CD004876.
29. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2011;12(1)36-44.
30. Rivetti D, Jefferson T, Thomas R, et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2006:CD004876.
31. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med. 1995;123(7):518-527.
32. Vu T, Farish S, Jenkins M, Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine. 2002;20(13-14):1831-1836.
33. Fedson DS, Wajda A, Nicol JP, Hammond GW, Kaiser DL, Roos LL. Clinical effectiveness of influenza vaccination in Manitoba. JAMA. 1993;270(16):1956-1961.
34. Legrand J, Vergu E, Flahault A. Real-time monitoring of the influenza vaccine field effectiveness. Vaccine. 2006;24(44-46):6605-6611.
35. Mullooly JP, Bennett MD, Hornbrook MC, et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med. 1994;121(12):947-952.
36. Nordin J, Mullooly J, Poblete S, et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J Infect Dis. 2001;184(6):665-670.
37. Nichol KL, Nordin J, Mullooly J, et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med. 2003;348(14):1322-1332.
38. Voordouw BC, van der Linden PD, Simonian S, van der Lei J, Sturkenboom MC, Stricker BH. Influenza vaccination in communitydwelling elderly: impact on mortality and influenza-associated morbidity. Arch Intern Med. 2003;163(9):1089-1094.
39. Hak E, Verheij TJ, Grobbee DE, Nichol KL, Hoes AW. Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications. J Epidemiol Community Health. 2002;56(12):951-955.
40. Hak E, Buskens E, van Essen GA, et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med. 2005;165(3): 274-280.
41. Hak E, Hoes AW, Nordin J, Nichol KL. Benefits of influenza vaccine in US elderly-appreciating issues of confounding, bias and precision. Int J Epidemiol. 2006;35(3):800-802.
42. Vila-Corcoles A, Rodriguez T, de Diego C, et al. Effect of influenza vaccine status on winter mortality in Spanish community-dwelling elderly people during 2002-2005 influenza periods. Vaccine. 2007; 25(37-38):6699-6707.
43. Simonsen L, Viboud C, Taylor RJ, Miller MA, Jackson LA. Influenza vaccination and mortality benefits: new insights, new opportunity. Vaccine. 2009;27(45):6300-6304.
44. Hottes TS, Skowronski DM, Hiebert B, et al. Influenza vaccine effectiveness in the elderly based on administrative databases: change in immunization habit as a marker for bias. PLoS One. 2011;6(7): e22618.
45. Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol. 2006;35(2):337-344.
46. Jackson LA, Nelson JC, Benson P, et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol. 2006;35(2):345-352.
47. Jackson LA. Benefits of examining influenza vaccine associations outside of influenza season. Am J Respir Crit Care Med. 2008;178(5): 439-440.
48. Jackson ML, Nelson JC, Weiss NS, Neuzil KM, Barlow W, Jackson LA. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested casecontrol study. Lancet. 2008;372(9636):398-405.
49. Sambhara S, McElhaney JE. Immunosenescence and influenza vaccine efficacy. Curr Top Microbiol Immunol. 2009;333:413-429.
50. McElhaney JE. Influenza vaccine response in older adults. Ageing Res Rev. 2011;10(3):379-388.
51. Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccine in the elderly: a quantitative review. Vaccine. 2006;24(8): 6808-6811.
52. Beyer WE, Palache AM, Baljet M, Masurel N. Antibody induction by influenza vaccines in the elderly: a review of the literature. Vaccine. 1989;7(5):385-394.
53. Skowronski DM, Tweed SA, De Serres G. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? J Infect Dis. 2008;197(4):490-502.
54. Talbot HK, Falsey AR. The diagnosis of viral respiratory disease in older adults. Clin Infect Dis. 2010;50(5):747-751.
55. Ebell MH, Alfonso A. A systematic review of clinical decision rules for the diagnosis of influenza. Ann Fam Med. 2011;9(1):69-77.
56. Nichol KL. Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversy. Vaccine. 2009;27(45):6305-6311.
57. Reichert T, Simonsen L, Shama A, Pardo SA, Fedson DS, Miller MA. Influenza and the winter increase in mortality in the United States, 1959-1999. Am J Epidemiol. 2004;160(5):492-502.
58. Fleming DM, Cross KW, Pannell RS. Influenza and its relationship to circulatory disorders. Epidemiol Infect. 2005;133(2):255-262.
59. Yu X, Tsibane T, McGraw PA, et al. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature. 2008; 455(7212):532-536.
60. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet. 2010;375(9720): 1100-1108.
61. Lang PO. Inactivated influenza vaccines: pre-vaccination haemagglutininantibody titres influence the vaccine response but not necessarily the vaccine effectiveness. Drugs Aging. 2011;28(6):505.
62. Sasaki S, He XS, Holmes TH, et al. Influence of prior influenza vaccination on antibody and B-cell responses. PLoS One. 2008;3(8): e2975.
63. Ohmit SE, Petrie JG, Cross RT, Johnson E, Monto AS. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccineinduced protection. J Infect Dis. 2011;204(12):1879-1885.
64. Feng J, Gulati U, Zhang X, et al. Antibody quantity versus quality after influenza vaccination. Vaccine. 2009;27(45):6358-6362.
65. Sasaki S, Sullivan M, Narvaez CF, et al. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J Clin Invest. 2011;121(8): 3109-3119.
66. Jefferson T. Influenza vaccination: policy versus evidence. BMJ. 2006;333(7574):912-915.
67. Fireman B, Lee J, Lewis N, Bembom O, van der Laan M, Baxter M. Influenza vaccination and mortality: differentiating vaccine effects from bias. Am J Epidemiol. 2009;170(5):650-656.
68. Thompson WW, Moore MR, Weintraub E, et al. Estimating influenzaassociated deaths in the United States. Am J Public Health. 2009;99 (Suppl 2):S225-S230.
69. Grubeck-Loebenstein B, Della Bella S, Iorio AM, Michel JP, Pawelec G, Solana R. Immunosenescence and vaccine failure in the elderly. Aging Clin Exp Res. 2009;21(3):201-209.
70. Fulop T, Pawelec G, Castle S, Loeb M. Immunosenescence and vaccination in nursing home. Clin Infect Dis. 2009;48(4):443-448.
71. Siegrist CA, Aspinall R. B-cell responses to vaccination at the extremes of age. Nat Rev Immunol. 2009;9(3):185-193.
72. Govind S, Lapenna A, Lang PO, Aspinall R. Immunotherapy of immunosenescence: who and how? Open Longev Sci. 2012. In press.
73. Lang PO, Aspinall R. Immunosenescence and herd immunity: with an ever increasing aging population do we need to rethink vaccine schedules? Expert Rev Vaccines. 2012. In press.
74. Lang PO, Govind S, Michel JP, Aspinall R, Mitchell WA. Immunosenescence: Implications for vaccination programmes in adults. Maturitas. 2011;68(4):322-330.
75. Thomas RE, Jefferson T, Lasserson TJ. Influenza vaccination for healthcare workers who work with the elderly. Cochrane Database Syst Rev. 2010:CD005187.
76. Thomas RE, Jefferson T, Lasserson TJ. Influenza vaccination for healthcare workers who work with the elderly: systematic review. Vaccine. 2010;29(2):344-356.
77. Lemaitre M, Meret T, Rothan-Tondeur M, et al. Effect of influenza vaccination of nursing home staff on mortality of residents: a clusterrandomized trial. J Am Geriatr Soc. 2009;57(9):1580-1586.
78. Hayward AC, Harling R, Wetten S, et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ. 2006;333(7581):1241.
79. Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet. 2000;355(9198):93-97.
80. Potter J, Stott DJ, Roberts MA, et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis. 1997;175(1):1-6.
81. Talbot TR, Dellit TH, Hebden J, Sama D, Cuny J. Factors associated with increased healthcare worker influenza vaccination rates: results from a national survey of university hospitals and medical centers. Infect Control Hosp Epidemiol. 2010;31(5):456-462.
82. Blank PR, Schwenkglenks M, Szucs TD. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. J Infect. 2009;58(6):446-458.
83. Weiskopf D, Weinberger D, Grubeck-Loebenstein B. The aging of the immune system. Transpl Int. 2009;22(11):1041-1050.